|June 2008 · Vol. 20, No. 06
Is hormonal contraception right for your perimenopausal patient?
In healthy patients, combination OCs and other hormonal methods have a lot to offer—as long as you’re mindful of risks in selected subgroups.
Pregnancy-related mortality among women 40 years or older in the US is five times higher than among 25- to 29-year-olds
Both ACOG and the World Health Organization recommend that perimenopausal migraineurs avoid combination estrogen–progestin contraceptives
OCs can restore physiologic bleeding patterns in older women who have dysfunctional uterine bleeding
A trial from Sweden found a 25% reduction in the risk of hip fracture among postmenopausal women who had used OCs
DMPA in contraceptive dosages has relieved vasomotor symptoms in menopausal women
Dr. Kaunitz is Professor and Associate Chairman, Department of Obstetrics and Gynecology, at the University of Florida College of Medicine in Jacksonville, Fla. He serves on the OBG Management Board of Editors.
The author reports research support from Barr, Bayer, Medical Diagnostic Laboratories, Organon, and Warner-Chilcott. He serves as a speaker or consultant for Barr, Bayer, Johnson & Johnson, Merck, Noven, Organon, and Warner-Chilcott. He holds stock in Procter & Gamble, Quest, and Sanofi-Aventis.